Lamotrigine Open Trial in Refractory Epilepsy

Abstract

Lamotrigine, 5 and 15 mg/kg/daily, was administered as add-on therapy in 37 outpatient children and adolescents with refractory epilepsy and mental delay treated at the Child Neuropsychiatry Unit, Department of Pediatrics, Second University of Naples, Italy.

Keywords

• generalized seizures
• refractory epilepsy
• seizure frequency